Major Congenital Malformation Risk Lower With Several Epilepsy Drugs
(MedPage Today) -- Levetiracetam, oxcarbazepine, and lamotrigine had the lowest prevalence of major congenital malformations (MCMs) compared with other monotherapy anti-seizure medications (ASMs) for pregnant women with epilepsy, a prospective... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 20, 2024 Category: Neurology Source Type: news
Levetiracetam Tops Lamotrigine for Some Women With Epilepsy Levetiracetam Tops Lamotrigine for Some Women With Epilepsy
Levetiracetam is superior to lamotrigine for initial monotherapy in female patients with juvenile myoclonic epilepsy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 3, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
FDA shows generic lamotrigine extended-release tablets are bioequivalent to innovator drug in fully replicated crossover bioequivalence study
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 26, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Association between the mood stabilizing treatment of bipolar disorder and risk of suicide attempts: a self-controlled case series study - Ng VWS, Leung MTY, Chan EW, Lee EHM, Hayes JF, Osborn DPJ, Wing YK, Lau WCY, Man KKC, Wong ICK.
This study aimed to examine the association between mood stabilizing agents (lithium, valproate, lamotrigine, ... (Source: SafetyLit)
Source: SafetyLit - May 18, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
Scientists 'CURE autism' using $3 epilepsy drug in mice - in potential breakthrough
Lamotrigine, brand name Lamictal, was able to curb behavioral and social problems linked to the disorder, which is becoming increasingly common in the US. (Source: the Mail online | Health)
Source: the Mail online | Health - February 14, 2023 Category: Consumer Health News Source Type: news
Starting Lamotrigine: Who Needs an EKG? Starting Lamotrigine: Who Needs an EKG?
Drs Wilner and French discuss the latest FDA label changes on lamotrigine and what they mean in practice.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - November 22, 2022 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
Is Lamictal Used as a Mood Stabilizer?
Title: Is Lamictal Used as a Mood Stabilizer?Category: MedicationsCreated: 3/2/2022 12:00:00 AMLast Editorial Review: 3/2/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - March 2, 2022 Category: Drugs & Pharmacology Source Type: news
For Antiseizure Med: Don't Panic but Beware of Cardiac Risks For Antiseizure Med: Don't Panic but Beware of Cardiac Risks
Although lamotrigine is"still a good drug" in epilepsy, it ' s crucial to take special precautions in high-risk groups such as older patients and those with cardiac conditions, experts say.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 20, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Lamotrigine for treating anger in veterans with posttraumatic stress disorder - Thompson SI, El-Saden SM.
Lamotrigine is an antiepileptic drug that was Food and Drug Administration approved in 2003 for use in the maintenance treatment of bipolar I disorder to delay the time to recurrence of new mood episodes. The mechanism by which lamotrigine achieves its the... (Source: SafetyLit)
Source: SafetyLit - September 22, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease
. FDA now requiring studies to evaluate heart risk across the drug class (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart disease who are taking the seizure and mental health medicine lamotrigine (Lamictal). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease
. FDA now requiring studies to evaluate heart risk across the drug class (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 31, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
More Reassurance for Certain Antiseizure Drugs in Pregnancy More Reassurance for Certain Antiseizure Drugs in Pregnancy
Further evidence supporting the safety of lamotrigine and levetiracetam has come from latest results from the MONEAD study.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Task Force Tackles FDA Lamotrigine Cardiac Risk Warning Task Force Tackles FDA Lamotrigine Cardiac Risk Warning
A joint international task force has issued an advisory to address concerns arising from an FDA warning of cardiac risk in patients taking the antiseizure drug lamotrigine.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 23, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Serotonin toxicity following suicide with citalopram and lamotrigine: a rare case report and literature review - Dorooshi G, Zoofaghari S, Meamar R.
We describe a case of serotonin toxicity in a 17-year-old woman, secondary to suicid... (Source: SafetyLit)
Source: SafetyLit - January 27, 2021 Category: International Medicine & Public Health Tags: Poisoning Source Type: news
